BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Rhea-AI Summary

BridgeBio Pharma (Nasdaq: BBIO), a biopharmaceutical company specializing in genetic diseases, announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference 2025. The company's management team will engage in a fireside chat session scheduled for Monday, June 9 at 8:40 am ET in Miami, FL. Investors and interested parties can access the live webcast through BridgeBio's investor relations website, with a replay available for 30 days following the event.

News Market Reaction – BBIO

+3.53%

1 alert

+3.53% News Effect

On the day this news was published, BBIO gained 3.53%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will participate in a fireside chat at the Goldman Sachs 46^th Annual Global Healthcare Conference 2025 in Miami, FL on Monday, June 9 at 8:40 am ET.

To access the live webcast of BridgeBio’s presentation during the fireside chat, please visit the “Events & Presentations” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcast will be available on the BridgeBio website for 30 days following the event.

About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio) is a new type of biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn, Twitter, Facebook, and YouTube.

BridgeBio Media Contact:
Bubba Murarka, Executive Vice President
contact@bridgebio.com  
(650)-789-8220

BridgeBio Investor Contact:
Chinmay Shukla, VP Strategic Finance
ir@bridgebio.com

FAQ

When is BridgeBio (BBIO) presenting at the Goldman Sachs Healthcare Conference 2025?

BridgeBio is scheduled to present at the Goldman Sachs Healthcare Conference on Monday, June 9, 2025, at 8:40 am ET in Miami, FL.

How can I watch BridgeBio's (BBIO) presentation at the Goldman Sachs Healthcare Conference?

The presentation can be accessed through the live webcast on BridgeBio's investor relations website at http://investor.bridgebio.com under the Events & Presentations page.

How long will BridgeBio's (BBIO) Goldman Sachs Conference presentation replay be available?

The webcast replay will be available on BridgeBio's website for 30 days following the event.

What type of presentation will BridgeBio (BBIO) give at the Goldman Sachs Healthcare Conference?

BridgeBio's management team will participate in a fireside chat format presentation at the conference.